Phenylalanine market is expected anoxia vs hypoxia to experience a swift development by 2024 – bitgmx

Phenylalanine is an amino acid that is found naturally in anoxia vs hypoxia the breast milk of mammals. As an essential amino acid, phenylalanine is not produced de novo in humans and other anoxia vs hypoxia animals, who need to ingest phenylalanine or phenylalanine-containing proteins. It is ingested into the body from foods such as anoxia vs hypoxia meat, poultry, fish, cottage cheese, lentils, peanuts, and sesame seeds. Phenylalanine is responsible for the production of molecules such as anoxia vs hypoxia tyrosine, epinephrine, norepinephrine, and dopamine. When the level of tyrosine in the body is low, tyrosine is formed through hydroxylation of phenylalanine in the liver. Tyrosine is primarily used to produce new proteins and it anoxia vs hypoxia is metabolized into epinephrine, norepinephrine, dopamine, and melanin, the tissue pigment. Epinephrine and norepinephrine are responsible for managing the stress level anoxia vs hypoxia in the body, while dopamine is primarily responsible for feeling of pleasure in anoxia vs hypoxia the brain.

Phenylalanine is primarily used for the treatment of depression, attention deficit-hyperactivity disorder (ADHD), parkinson’s disease, multiple sclerosis, vitiligo, acupuncture anesthesia, osteoarthritis, rheumatoid arthritis, weight loss, and alcohol withdrawal symptoms. Being a protein-producing amino acid, phenylalanine is used for regulating the anxiety and depression levels. With rise in the rate of incidence of depression among anoxia vs hypoxia different age groups, is anticipated to drive the global phenylalanine market. People born with a higher level of phenylalanine in the anoxia vs hypoxia blood are inherited with a disorder called phenylketonuria (PKU). Phenylketonuria is a rare genetic condition that is caused by anoxia vs hypoxia buildup of phenylalanine in the body. Common symptoms of PKU include seizures, hyperactivity, tremors, musty odor of breath, and sluggish growth. This, in turn, acts as a restraint of the global phenylalanine market.

The global phenylalanine market is driven by growth of the anoxia vs hypoxia global pharmaceutical industry. Phenylalanine is used as a neurotransmitter in the central nervous anoxia vs hypoxia system, for stimulating the brain cells. It acts as an effective pain reliever. Additionally, it is used in the treatment of premenstrual syndrome and anoxia vs hypoxia parkinson’s disease in order to increase the effects of acupuncture anoxia vs hypoxia and transcutaneous electrical nerve stimulation (TENS). DL-phenylalanine is used as a nutritional supplement owing to its anoxia vs hypoxia analgesic and antidepressant properties.

In terms of region, the global phenylalanine market can be segmented into asia pacific, europe, north america, middle east & africa, and latin america. Asia pacific is anticipated to constitute a major share of anoxia vs hypoxia the global market during the forecast period. China and india are highly populated countries and they are anoxia vs hypoxia witnessing rise in the anxiety and depression levels among people. This is likely to boost the demand for long-term treatment of diseases and, in turn, the demand for phenylalanine in the region in the next anoxia vs hypoxia few years. Increase in affordability of drugs, led by rising number of launches of low-priced generics, is fueling the demand for drugs. This, in turn, is driving the global phenylalanine market. The U.S and countries in europe are anticipated to experience higher anoxia vs hypoxia adoption of phenylalanine in the next few years, due to increase in the number of health care facilities anoxia vs hypoxia and availability of drugs for depression and chronic pain in anoxia vs hypoxia these countries.